Wikidata

(Q61975265)

English

Efficacy Study Comparing Velcade Dexamethasone Thalidomide Versus Velcade Cyclophosphamide Dexamethasone as Induction Treatment in the Initial Management of Multiple Myeloma (IFM2013-04)

clinical trial

In more languages

Statements

short name
IFM2013-04 (English)
0 references
title
A PHASE III STUDY OF VELCADE (BORTEZOMIB) THALIDOMIDE DEXAMETHASONE (VTD) VERSUS VELCADE (BORTEZOMIB) CYCLOPHOSPHAMIDE DEXAMETHASONE (VCD) AS AN INDUCTION TREATMENT PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA." (English)
0 references
country
France
0 references
start time
October 2013
0 references
end time
August 2015
0 references
number of participants
358
0 references
research intervention
dexamethasone acetate
0 references
(RS)-cyclophosphamide
0 references
bortezomib
0 references
thalidomide
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61975265&oldid=2130131085"